# RenovoRx, Inc. (RNXT): MoatMap facts

As of 27 Oct 2026. Research data, not investment advice.

As of 27 Oct 2026, MoatMap's StockRank for RenovoRx, Inc. (RNXT) is 23/100, ranked against 24,000+ stocks in 35 markets (Quality 26, Value 23, Momentum 58, each scored against its sector).

- StockRank: 23/100, a percentile across 24,000+ stocks in 35 markets (100 is best).
- Quality 26, Value 23, Momentum 58: each a 0-100 percentile within Healthcare.
- Position: #20,272 overall, #1,804 in Healthcare.
- Listing: United States, NCM; Healthcare / Biotechnology.
- Last close: 1.31 USD on 26 Oct 2026.
- Insider filings, last 180 days: directors bought USD 20K.

Source: https://moatmap.ai/stock/RNXT
How the scores work: https://moatmap.ai/methodology
Does StockRank work? The public record: https://moatmap.ai/decile-tracker